Biota Pharmaceuticals (United States)
- Research works
- 111 ▲ 116% vs 2018-21
- Citations
- 1.6k 14.0 per fractional work
- Top-10% rate
- 8.2% all institutions 10.0%
- Open access
- 52% world 40%
- International
- 36% world 18%
Not ranked overall: Biota Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Biota Pharmaceuticals (United States) work in?
In 2022-now, 41% of research at Biota Pharmaceuticals (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (24%), Environmental Science (8%). It does 2.4× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 20 fields, with their numbers
- Life Sciences1741.0%
- Health Sciences1536.2%
- Physical Sciences819.5%
- Environmental Science48.4%
- Engineering25.4%
- Computer Science12.1%
- Chemistry11.8%
- Energy00.8%
- Earth and Planetary Sciences00.4%
- Materials Science00.4%
- Chemical Engineering00.2%
- Social Sciences13.3%
- Social Sciences11.4%
- Economics, Econometrics and Finance11.2%
- Decision Sciences00.4%
- Psychology00.3%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.4×. Every wedge is a field page.
All 20 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics9.40×1 works
- Immunology and Microbiology5.35×2 works
- Biochemistry, Genetics and Molecular Biology4.55×10 works
- Nursing3.19×1 works
- Medicine1.79×15 works
- Environmental Science1.69×4 works
- Agricultural and Biological Sciences1.59×3 works
- Chemistry1.15×1 works
- Energy0.88×0 works
- Chemical Engineering0.67×0 works
- Economics, Econometrics and Finance0.58×0 works
- Decision Sciences0.40×0 works
- Engineering0.36×2 works
- Neuroscience0.34×0 works
- Dentistry0.32×0 works
- Computer Science0.27×1 works
- Earth and Planetary Sciences0.27×0 works
- Social Sciences0.11×1 works
- Materials Science0.10×0 works
- Psychology0.08×0 works
- Pharmacology, Toxicology and Pharmaceutics 9.4×
- Immunology and Microbiology 5.3×
- Biochemistry, Genetics and Molecular Biology 4.5×
- Nursing 3.2×
- Medicine 1.8×
- Environmental Science 1.7×
- Agricultural and Biological Sciences 1.6×
- Chemistry 1.1×
- Energy 0.9×
- Chemical Engineering 0.7×
- Economics, Econometrics and Finance 0.6×
- Decision Sciences 0.4×
- Engineering 0.4×
- Neuroscience 0.3×
- Dentistry 0.3×
- Computer Science 0.3×
- Earth and Planetary Sciences 0.3×
- Social Sciences 0.1×
- Materials Science 0.1×
- Psychology 0.1×
Who are the top researchers at Biota Pharmaceuticals (United States)?
Ranked on the quality score, Jennifer L. Brooks, Patrick C. Fagan and Thomas W. Bruice lead among researchers whose main affiliation is Biota Pharmaceuticals (United States).
- 1
Jennifer L. Brooks
United States · #1,287,983 worldwide 1.5k citations · 40 works
- 2
Patrick C. Fagan
United States · #1,850,042 worldwide 760 citations · 21 works
- 3
Thomas W. Bruice
United States · #2,129,284 worldwide 1.2k citations · 22 works
- 4
Ben Harrison
United States · #2,813,370 worldwide 177 citations · 25 works
Which keywords describe research at Biota Pharmaceuticals (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Antioxidant, Cancer, Oxidative Stress, Inflammation, Data Integration, Regeneration, Targeted Therapy and Gene Expression.
- SARS-CoV-2
- Nutrition
- Circular Economy
- Skin Microbiome
- Neurological Disorders
- Angiogenesis
- Regeneration
- Immune Response
- Innovation
- Gene Expression
- Oxidative Stress
- Epidemiology
- Cancer
- Inflammation
- Antioxidant
- Data Integration
- Clinical Trials
- Immunotherapy
- Targeted Therapy
- Filaggrin
- Pathogenesis
- Sustainability
- Data Sharing
- RNA-Seq
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Cancer3▲ 4.6×11 topics
- Epidemiology2▲ 1.42×12 topics
- Inflammation2▲ 2.7×12 topics
- Oxidative Stress2▲ 3.3×12 topics
- Antioxidant2▲ 7.5×10 topics
- Gene Expression1▲ 5.2×5 topics
- Data Integration1▲ 18×2 topics
- Innovation1▲ 3.0×2 topics
- Clinical Trials1▲ 4.2×7 topics
- Immune Response1▲ 5.1×6 topics
- Immunotherapy1▲ 4.0×4 topics
- Regeneration1▲ 14×3 topics
- Targeted Therapy1▲ 12×3 topics
- Angiogenesis1▲ 7.5×4 topics
- Filaggrin1▲ 50×1 topic
- Neurological Disorders1▲ 4.5×4 topics
- Pathogenesis1▲ 5.2×4 topics
- Skin Microbiome1▲ 50×1 topic
- Sustainability1◆ 1.10×7 topics
- Circular Economy1▲ 8.6×2 topics
- Data Sharing1▲ 73×2 topics
- Nutrition1▲ 5.3×3 topics
- RNA-Seq1▲ 20×2 topics
- SARS-CoV-21▲ 7.7×3 topics
Which research topics does Biota Pharmaceuticals (United States) publish most on?
By volume in 2022-now: Dermatology and Skin Diseases, Cancer Genomics and Diagnostics, Single-cell and spatial transcriptomics and Genetically Modified Organisms Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Dermatology and Skin Diseases Dermatology 1 works
- 2 Cancer Genomics and Diagnostics Cancer Research 1 works
- 3 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 4 Genetically Modified Organisms Research Plant Science 1 works
- 5 Research Data Management Practices Information Systems 1 works
- 6 Bioeconomy and Sustainability Development General Agricultural and Biological Sciences 1 works
- 7 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
- 8 Trace Elements in Health Nutrition and Dietetics 1 works
- 9 Phytochemicals and Medicinal Plants Complementary and alternative medicine 1 works
- 10 RNA Research and Splicing Molecular Biology 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Biota Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 116% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Biota Pharmaceuticals (United States) as a percentage of every work published that year, 0.00015% in 2024.
Fractional works of Biota Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Alpharetta
- Pediatrics and Genetics
- Engineering Associates (United States)
- Institute for Advanced Medical Research
- Chinese Medical Center
- Clearside Biomedical (United States)
- Alimera Sciences (United States)
- Veloxiti (United States)
- Rolta (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Biota Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.